Arkolith/Insider Trading/RMD/Form 4

Farrell Michael J.

Chairman and CEO, DirectorRESMED INC (RMD) · full profile →Form 4 · filed May 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 7, 2026Option exercise(M)5K$146.34$730K471K
May 7, 2026Sell(S)5K$207.82$1.0M466K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2026Option exercise(M)5K—$030K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000943819-26-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML